STOCKS TELEGRAPH

Tag: Ocugen Inc

  • Ocugen Inc. (OCGN) stock Soars Higher in the After Hours. Reasons?

    Ocugen Inc. (OCGN) stock gained a further 16.03% in the after-hours at $6.08 on December 17. The stock seems to continue gaining on its Covid-19 vaccines candidate’s positive data after a small profit booking event.

    In the previous trading session, the stock gained 4.38% at $5.24 with 21.1 million shares exchanging. The gain multiplied in the after-hours as the stock reached $6.08 at a volume of 8.27 million shares.

    Currently, the 199.19 million outstanding shares of OCGN trade at a market capitalization of $1.04 billion.

    What is Happening?

    On December 15, positive new data from the company’s Covid-19 vaccine candidate COVAXINTM was shared. Following the announcement, the OCGN stock became bullish and started gaining big. After gaining a good deal on December 15, the stock suffered some loss the next day, due to profit booking. Currently, the stock seems to be back on the bullish path, continuing to gain on the previous news.

    In the past five sessions, the stock has lost 2.06%, while losing 32.12% last month. Moreover, OCGN has suffered a decrease of 33.92% in the past three months, while it gained 186.34% year to date. In addition, the one-year gain of the stock stands at a whopping 1,685.35%.

    OCGN’s COVAXINTM Data

    As per the data published by a third party, OCGN’s study of COVAXIN resulted in a robust and positive response. The vaccine developed active immune memory against spike and nucleoprotein, as compared to natural Covid-19 infection. The adaptive immune system generates long-term protection against a virus by creating memory B and T cells. Moreover, it also controls the infection.

    During the study, the immune memory response of 71 vaccinated subjects was compared to that of 73 naturally infected subjects.

    According to the data, in almost 85% of subjects, COVAXIN created T-cells against spike and nucleocapsid proteins. This persisted for a minimum of six months, hence supporting COVAXIN’s ability to induce long-term memory.

    Currently, OCGN is conducting COVAXIN’s study to check its efficacy against the omicron variant. Moreover, the company will share the data as soon as possible.

    Financials of the Company

    On November 09, OCGN announced the financial results of the third quarter of 2021. In the third quarter of 2021, the net loss was $0.05 per share, against $0.07 in the year-ago quarter.

    Moreover, OCGN ended the quarter with cash, cash equivalents, and restricted cash of $107.5 million.

  • Why Is Ocugen (OCGN) Stock Increasing Today?

    The shares of Ocugen Inc. (OCGN) are up 3.58% to $6.67 in early trading this morning. The Ocugen stock was down by -4.17% to $6.44 at the end of the last trading session. There were 13.28 million shares traded in OCGN stock yesterday. That was below the volume of 44.31 million shares in a daily average for the past 50 days.

    OCGN stock has declined 10.06 percent in the last five days; however, it has gained 5.06% over the past month. Over the last three months, the stock price of OCGN has shed -6.67% and is up 251.91% so far this year. In response to a submission to the Canadian health authority, OCGN stock is rising.

    What OCGN has been submitting?

    As a biopharmaceutical company, Ocugen aims to discover, develop, and commercialize gene therapies for blindness diseases and to develop a vaccine against COVID-19. OCGN’s breakthrough platform for gene therapy, which treats multiple retinal diseases with one drug, has the potential to treat multiple diseases with the same drug.

    With OCGN’s novel biologic product candidate, patients with diseases like wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy will be able to receive better treatment options. Bharat Biotech’s COVAXIN, a vaccine candidate for COVID-19, is being co-developed by OCGN in the United States and Canada.

    A rolling submission for COVAXIN has been made to Health Canada by Ocugen, announced the company in a press release today. Following the publication of results from Bharat Biotech’s Phase 3 clinical trial, which showed efficacy and safety in nearly 25,800 adults, OCGN intends to make this move.

    The Minister of Health recommended and accepted the rolling submission process relating to the importation, sale and advertising of drugs for use with COVID-19 and transitioned to the New Drug Submission for COVID-19, which will allow companies to submit safety and efficacy information as it becomes available. Often referred to as rolling reviews, this allows Health Canada to begin its review immediately as new information becomes available, allowing the overall review process to move faster.

    How OCGN will proceed?

    In the rolling submission, Ocugen (OCGN) is represented by its affiliate, Vaccigen, Ltd. OCGN must submit evidence that supports the safety, effectiveness, and quality of their product to Health Canada for review. OCGN will work with Health Canada to bring another safe and effective option for the fight against COVID-19 and its Delta variant, and will be supporting Health Canada for their upcoming review of COVAXIN.

  • What changed for these 50 stocks in Pre-Market Session?

    What changed for these 50 stocks in Pre-Market Session?

    Naked Brand Group Limited (NAKD) stock plunged -10.0% to $0.26 in the pre-market trading.

    Arcimoto Inc. (NASDAQ: FUV) shares are trading down -8.25% at $14.68 at the time of writing after Arcimoto and the city of Orlando launched a joint municipal pilot program to test ultra-efficient Electric Vehicles in city fleets. The company’s 52-week range was noted as $0.97 to $10.49. Analysts have a consensus price target of $8.

    HighPoint Resources Corporation (HPR) tumbled over -5.56% at $10.7 in pre-market trading today after Laredo Petroleum announced the appointment of Jarvis Hollingsworth and Lori Lancaster to the board of directors.

    Phoenix New Media Limited (FENG), an Internet Content & Information company, dropped about -4.29% at $2.23 in pre-market trading Friday after the company announced a special cash dividend of US$1.3712 per ADS.

    Ayro Inc. (AYRO) stock moved up 7.12 percent to $6.62 in the pre-market trading as the company revealed Q3 results.

    Titan Pharmaceuticals Inc. (TTNP) gained over 59.94% at $0.2735 in pre-market trading Friday 20 November 2020 following the announcement of its quarterly results.

    VAALCO Energy Inc. (EGY) is down more than -6.21% at $1.66 in pre-market hours Friday 20 November 2020 as the company announced that it has signed a sale and purchase agreement to acquire Sasol Gabon S.A.’s 27.8% working interest in the Etame Marin block offshore Gabon. The stock had jumped over 31.11% to $1.77 in the last trading session.

    Before the trading started on 20 November 2020, CIIG Merger Corp. (CIIC) is down -3.18% to reach $16.46. It has been trading in a 52-week range of $9.30 to $13.70.

    Kandi Technologies Group Inc. (KNDI) stock plunged -1.53% to $14.19 in the pre-market trading as the news surfaced that the company’s EV is entitled to a $2,500 Rebate in Texas.

    Nano Dimension Ltd. (NASDAQ: NNDM) shares are trading down -28.33% at $4.2 at the time of writing after the company revealed it has entered into definitive agreements with investors for the sale of 25,000,000 of the Company’s American Depositary Shares at a price of $4.00 per ADS pursuant to a registered direct offering. The company’s 52-week range was noted as $0.51 to $6.00. Analysts have a consensus price target of $8.

    Medigus Ltd. (MDGS) tumbled over -0.81% at $2.45 in pre-market trading today. Correction after the news that the company aimed to form a joint venture with EMuze founders to develop and potentially commercialize EV-based micro-mobility vehicles for urban and logistics transportation.

    TransAtlantic Petroleum Ltd. (TAT), an Oil & Gas E&P company, rose about 13.65% at $0.2839 in pre-market trading Friday as the company revealed its Q3 results as offered a business update.

    Hudson Capital Inc. (HUSN) stock moved down -6.69 percent to $2.51 in the pre-market trading after the report of Hudson Capital Inc. and FreightHub, Inc. progressed further with the planned merger.

    Youdao Inc. (DAO) lost over -2.21% at $29.25 in pre-market trading Friday 20 November 2020 after the company reported third-quarter 2020 unaudited financial results.

    Jumia Technologies AG (JMIA) is down more than -2.6% at $23.6 in pre-market hours Friday 20 November 2020 after the reported that the company is finally narrowing losses after the pandemic forced a strategy shift. The stock had jumped over 18.37% to $24.23 in the last trading session.

    Before the trading started on 20 November 2020, CBAK Energy Technology Inc. (CBAT) is down -3.43% to reach $7.33. It has been trading in a 52-week range of $0.36 to $11.40.

    Polar Power Inc. (POLA) stock plunged -3.15% to $4.0 in the pre-market trading. The most recent rating by ROTH Capital, on November 07, 2017, is at a Neutral.

    Westwater Resources Inc. (NASDAQ: WWR) shares are trading up 5.48% at $6.16 at the time of writing after the company revealed Q3 results and offered a business update. The company’s 52-week range was noted as $0.25 to $14.50.

    Oragenics Inc. (OGEN) tumbled over -18.33% at $0.4296 in pre-market trading today after the Company announced that it has commenced a proposed underwritten public offering of common stock of the Company.

    Euroseas Ltd. (ESEA), a Marine Shipping company, dropped about -22.56% at $3.09 in pre-market trading Friday after the firm posted results for the nine-month period and the quarter ended September 30, 2020.

    Fuel Tech Inc. (FTEK) stock moved up 4.5 percent to $1.16 in the pre-market trading as the company revealed Q3 earnings report.

    SPI Energy Co. Ltd. (SPI) lost over -3.1% at $8.45 in pre-market trading Friday 20 November 2020 after the firm closed the sale of a 1.015-megawatt solar project in Maui, Hawaii.

    SG Blocks Inc. (SGBX) is down more than -12.28% at $2.5 in pre-market hours Friday 20 November 2020 after the publications reported that SG Blocks to deliver up to 7,000 COVID-19 PCR tests per shift leveraging Its state-of-the-Art D-TEC module lab solutions. The stock had jumped over 8.78% to $2.85 in the last trading session.

    Before the trading started on 20 November 2020, Senmiao Technology Limited (AIHS) is down 0.0% to reach $1.16, as the company revealed that it has recently launched Xixingtianxia, its own proprietary online ride-sharing platform, to drivers and riders in Chengdu, China, one of its core cities with a population of approximately 16 million. It has been trading in a 52-week range of $0.26 to $2.35.

    Teligent Inc. (TLGT) stock soared 11.65% to $0.6 in the pre-market trading after the company revealed adjournment of a special meeting of stockholders. The most recent rating by Craig Hallum, on August 20, 2020, is at a Hold.

    Waitr Holdings Inc. (NASDAQ: WTRH) shares are trading up 13.45% at $3.88 at the time of writing after the company revealed a Q3 earnings beat. The company’s 52-week range was noted as $0.26 to $5.85. Analysts have a consensus price target of $8.

    Ocean Power Technologies Inc. (OPTT) grew over 7.43% at $2.17 in pre-market trading today after the company revealed receipt of a DeepStar project award to study the deployment and operational requirements of utilizing OPT’s PB3 PowerBuoy to provide remotely controllable zero-carbon power for deepwater subsea oil production applications.

    Artelo Biosciences Inc. (ARTL), a Biotechnology company, rose about 42.51% at $0.8301 in pre-market trading Friday after the company announced receipt of the Clinical Trial Authorization in the UK for the Company’s Cancer Appetite Recovery Study.

    U.S. Energy Corp. (USEG) stock moved up 4.96 percent to $3.6 in the pre-market trading as the company revealed Q3 fiscal and operating results.

    Insignia Systems Inc. (ISIG) lost over -4.4% at $0.87 in pre-market trading Friday 20 November 2020 after the company revealed Q3 and nine months results.

    ADiTx Therapeutics Inc. (ADTX) is down more than -3.43% at $1.97 in pre-market hours Friday 20 November 2020. The stock had jumped over 5.70% to $2.04 in the last trading session. after company secures CLIA certification for AditxtScore Laboratory Operations in Richmond, VA, and plans to launch AditxtScore for COVID-19 as a lab-developed test.

    Before the trading started on 20 November 2020, FuelCell Energy Inc. (FCEL) is down -2.99% to reach $5.2 after the stock rally forced analysts to keep the stock status recommended. It has been trading in a 52-week range of $0.48 to $5.80.

    Lightbridge Corporation (LTBR) stock plunged -5.14% to $2.95 in the pre-market trading as the company revealed Q3 results.

    GSX Techedu Inc. (NYSE: GSX) shares are trading down -12.17% at $62.67 at the time of writing after the firm revealed its third-quarter 2020 results. The company’s 52-week range was noted as $14.21 to $141.78. Analysts have a consensus price target of $38.

    Reed’s Inc. (REED) tumbled over -21.09% at $0.5998 in pre-market trading today. Reed’s Inc after the company revealed outlook for fiscal 2021.

    Hibbett Sports Inc. (HIBB), a Specialty Retail company, rose about 6.81% at $45.0 in pre-market trading Friday after firm earnings results topped estimates.

    Amarin Corporation plc (AMRN) stock moved up 16.74 percent to $5.3 in the pre-market trading as the company shared topline data from the pivotal phase 3 study of VASCEPA® in mainland China.

    Ocugen Inc. (OCGN) gained over 6.48% at $0.34 in pre-market trading Friday 20 November 2020 as the company revealed a business update with Q3 results.

    Vaxart Inc. (VXRT) is up more than 0.51% at $5.94 in pre-market hours Friday 20 November 2020 after the company announced hosting a key opinion leader panel call for investors. The stock had jumped over 3.68% to $5.91 in the last trading session.

    Before the trading started on 20 November 2020, Spectrum Pharmaceuticals Inc. (SPPI) is down -2.12% to reach $4.15. It has been trading in a 52-week range of $1.74 to $10.57.

    Workday Inc. (WDAY) stock plunged -2.9% to $224.11 in the pre-market trading after the company announced fiscal 2021 third-quarter financial results. The most recent rating by Piper Sandler, on October 20, 2020, is at an Overweight.

    NovaBay Pharmaceuticals Inc. (AMEX: NBY) shares are trading up 16.24% at $0.68 at the time of writing as the company published its Q3 earnings report. The company’s 52-week range was noted as $0.24 to $1.94. Analysts have a consensus price target of $1.10.

    Seelos Therapeutics Inc. (SEEL) tumbled over -6.84% at $0.7521 in pre-market trading today after the company received US orphan drug designation for SLS-005 in Amyotrophic Lateral Sclerosis.

    Catalyst Pharmaceuticals Inc. (CPRX), a Biotechnology company, dropped about -2.71% at $3.23 in pre-market trading Friday after analysts changed forecast following an earnings beat.

    360 DigiTech Inc. (QFIN) stock moved up 9.21 percent to $13.52 in the pre-market trading as the company revealed third quarter 2020 Unaudited financial results.

    Lyft Inc. (LYFT) lost over -2.77% at $39.0 in pre-market trading Friday 20 November 2020 following a report that Motional got approval to test fully driverless vehicles in Nevada.

    Corbus Pharmaceuticals Holdings Inc. (CRBP) is down more than -2.48% at $1.18 in pre-market hours Friday 20 November 2020. The stock had jumped over 0.83% to $1.21 in the last trading session.

    Before the trading started on 20 November 2020, BOQI International Medical Inc. (BIMI) is down -2.2% to reach $1.78. It has been trading in a 52-week range of $1.50 to $7.40 following the announcement of its quarterly results.

    FireEye Inc. (FEYE) stock soared 13.97% to $16.23 in pre-market trading. The most recent rating by BMO Capital Markets, on July 29, 2020, is at a Market performance after the firm revealed the acquisition of respond software.

    Akerna Corp. (NASDAQ: KERN) shares are trading down -2.91% at $2.67 at the time of writing after the report that cannabis sales expected to reach approximately $270M over thanksgiving weekend. The company’s 52-week range was noted as $2.17 to $13.50. Analysts have a consensus price target of $18.

     

  • What changed for these 46 stocks in Pre Market Session?

    What changed for these 46 stocks in Pre Market Session?

    Alterity Therapeutics Limited (ATHE) stock plunged -10.31% to $2.0 in the pre-market trading after the company announced the approval of a US patent for the next generation.

    Cinedigm Corp. (NASDAQ: CIDM) shares are trading down -4.55% at $0.525 at the time of writing after it posted Second Quarter Fiscal 2021 Earnings. The company’s 52-week range was noted as $0.25 to $6.00. Analysts have a consensus price target of $3.50.

    iBio Inc. (IBIO) tumbled over -2.34% at $1.67 in pre-market trading today as the Company revealed fiscal first quarter 2021 Financial results and provides a business update.

    CBAK Energy Technology Inc. (CBAT), an Electrical Equipment & Parts company, dropped about -7.4% at $9.01 in pre-market trading Wednesday.

    Comstock Mining Inc. (LODE) stock moved down -1.96 percent to $1.0 in the pre-market trading as it revealed to Host Earnings Call.

    CureVac N.V. (CVAC) lost over -3.01% at $74.19 in pre-market trading Wednesday 18 November 2020 after the news that the Company has established a European-based network to ramp Up manufacturing of its COVID-19 vaccine candidate, CVnCoV.

    Oncternal Therapeutics Inc. (ONCT) is down more than -24.88% at $3.11 in pre-market hours Wednesday 18 November 2020 as the Company increases previously revealed bought deal to $22.5 million. The stock had dropped over -9.41% to $4.14 in the last trading session.

    Before the trading started on 18 November 2020, New Concept Energy Inc. (GBR) is down -11.38% to reach $1.48 after the firm announced its Q3, 2020 results. It has been trading in a 52-week range of $0.55 to $2.19.

    Polar Power Inc. (POLA) stock plunged -7.25% to $3.07 in the pre-market trading. The most recent rating by ROTH Capital, on November 07, 2017, is at a Neutral.

    Trinity Biotech plc (NASDAQ: TRIB) shares are trading down 0.0% at $2.9 at the time of writing. The company’s 52-week range was noted as $0.56 to $3.35 as the company set to Host an Earnings Call.

    So-Young International Inc. (SY) grew over 4.65% at $13.5 in pre-market trading today as the company said it is going to report its earnings to result on November 25, 2020.

    BioNTech SE (BNTX), a Biotechnology company, rose about 4.22% at $90.6 in pre-market trading Wednesday after the report that Pfizer and BioNTech planned to file as vaccine proves 95% effective.

    Sunworks Inc. (SUNW) stock moved down -4.91 percent to $3.68 in the pre-market trading after the Company revealed that the proposed merger with the Peck Company Holdings, Inc. failed to secure stockholder approval.

    Sundial Growers Inc. (SNDL) lost over -3.04% at $0.2424 in pre-market trading Wednesday 18 November 2020 following the announcement of its third-quarter earnings results.

    Tuniu Corporation (TOUR) is up more than 1.04% at $1.95 in pre-market hours Wednesday 18 November 2020. The stock had dropped over -3.98% to $1.93 in the last trading session.

    Before the trading started on 18 November 2020, Taiwan Semiconductor Manufacturing Company Limited (TSM) is up 3.22% to reach $98.79 following the report that Samsung heats up chip wars with the claim that it can catch TSMC by 2022. It has been trading in a 52-week range of $42.70 to $102.44.

    Hill International Inc. (HIL) stock plunged -5.49% to $1.55 in the pre-market trading as the company said that CEO Raouf Ghali and CFO Todd Weintraub are scheduled to present at the following investor conferences during the month of November.

    Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) shares are trading down -4.77% at $0.5615 at the time of writing after the preliminary results following vaccination of non-human primates with TNX-1800 a live attenuated COVID-19 vaccine candidate engineered to express the SARS-CoV-2 spike protein after vaccination. The company’s 52-week range was noted as $0.39 to $2.46. Analysts have a consensus price target of $4.

    Genius Brands International Inc. (GNUS) tumbled over -3.42% at $1.13 in pre-market trading today after the company revealed strategic takeover of ChizComm Ltd. and ChizComm Beacon Media.

    Medley Management Inc. (MDLY), an Asset Management company, rose about 33.73% at $9.0 in pre-market trading Wednesday announced third-quarter earnings results.

    China SXT Pharmaceuticals Inc. (SXTC) stock moved down -3.59 percent to $0.2603 in the pre-market trading.

    Camtek Ltd. (CAMT) lost over -3.64% at $19.05 in pre-market trading Wednesday 18 November 2020 following the news of the commencement of a proposed underwritten public offering of three million ordinary shares.

    Cellectis S.A. (CLLS) is up more than 5.58% at $20.8 in pre-market hours Wednesday 18 November 2020, after the firm announced the appointment of Kyung Nam-Wortman as Cellectis’ Executive Vice President, Chief Human Resources Officer. The stock had dropped over -1.79% to $19.70 in the last trading session.

    Before the trading started on 18 November 2020, TechnipFMC plc (FTI) is up 4.34% to reach $8.42 after the Company received notice to proceed with the EPC contract for Sempra LNG’s and IEnova’s Energía Costa Azul LNG facility. It has been trading in a 52-week range of $4.49 to $21.84.

    Li Auto Inc. (LI) stock soared 3.17% to $36.16 in the pre-market trading after the Company revealed the 3rd quarter of 2020 Earnings results. The most recent rating by Citigroup, on November 16, 2020, is at a Buy.

    BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) shares are trading down -2.47% at $2.76 at the time of writing. The company’s 52-week range was noted as $2.35 to $62.00.

    Neptune Wellness Solutions Inc. (NEPT) tumbled over -2.63% at $1.85 in pre-market trading today after the company posted 2nd quarter loss and missed the predictions.

    Livent Corporation (LTHM), a Specialty Chemicals company, rose about 4.19% at $15.9 in pre-market trading Wednesday following the report of Analysts revised their forecast after disappointing Earnings.

    Micro Focus International plc (MFGP) stock moved up 29.73 percent to $4.8 in the pre-market trading.

    Houghton Mifflin Harcourt Company (HMHC) gained over 5.63% at $3.0 in pre-market trading Wednesday 18 November 2020 after the Company announced financial results for the quarter ended September 30, 2020. The Company revealed its plan to explore the potential sale of HMH Books & Media, its Consumer Publishing business.

    Acasti Pharma Inc. (ACST) is up more than 3.81% at $0.218 in pre-market hours Wednesday 18 November 2020 as the Company offered a business update for Q2, 2020. The stock had jumped over 0.77% to $0.21 in the last trading session.

    Before the trading started on 18 November 2020, Canaan Inc. (CAN) is up 8.73% to reach $3.61. It has been trading in a 52-week range of $1.76 to $13.00.

    VAALCO Energy Inc. (EGY) stock soared 45.1% to $1.48 in pre-market trading.

    Liminal BioSciences Inc. (NASDAQ: LMNL) shares are trading up 11.37% at $4.31 at the time of writing posted third-quarter results. The company’s 52-week range was noted as $3.51 to $31.45.

    Carver Bancorp Inc. (CARV) grew over 3.89% at $6.95 in pre-market trading today.

    Vaxart Inc. (VXRT), a Biotechnology company, dropped about -2.47% at $5.53 in pre-market trading Wednesday after it publicized that it is set to host a Key Opinion Leader (KOL) panel for investors entitled “An Oral Tablet Vaccine – A Potential Global Solution to COVID-19 and Norovirus?” on Thursday, November 19, 2020, at 12pm Eastern Time.

    SCWorx Corp. (WORX) stock moved down -3.64 percent to $1.06 in the pre-market trading.

    Sunoco LP (SUN) lost over -7.0% at $27.11 in pre-market trading Wednesday 18 November 2020 as the Company gained above 5% as Q3 Earnings topped predictions.

    NIO Limited (NIO) is up more than 3.78% at $48.35 in pre-market hours Wednesday 18 November 2020 as the Company revealed its Q3 loss less than expected, whiles sales topped predictions. The stock had jumped over 2.22% to $46.59 in the last trading session.

    Before the trading started on 18 November 2020, Ocugen Inc. (OCGN) is up 4.27% to reach $0.3029 as Company recently revealed Q3 results. It has been trading in a 52-week range of $0.17 to $0.96.

    Weidai Ltd. (WEI) stock soared 9.4% to $1.63 in the pre-market trading after the report that the Company regained compliance after receipt of NYSE Non-compliance letter regarding ADS trading price on October 20, 2020. The most recent rating by Morgan Stanley, on January 21, 2020, is at an Underweight.

    Magnolia Oil & Gas Corporation (NYSE: MGY) shares are trading up 2.99% at $6.2 at the time of writing after the Company missed Earnings predictions. The company’s 52-week range was noted as $3.23 to $13.28.

    Waitr Holdings Inc. (WTRH) grew over 13.68% at $3.24 in pre-market trading today as the Company beat the Earnings outlook.

    Norwegian Cruise Line Holdings Ltd. (NCLH), a Travel Services company, dropped about -6.17% at $20.7 in pre-market trading Wednesday after the company revealed the pricing of 40,000,000 ordinary shares.

    IZEA Worldwide Inc. (IZEA) stock moved up 5.49 percent to $0.77 in the pre-market trading as it revealed Q3 financial results.

    The Boeing Company (BA) gained over 3.53% at $217.46 in pre-market trading Wednesday 18 November 2020 after the report that Boeing’s 737 Max cleared to fly in the US after crashes.

     

  • 20 Trending Stocks In Biotechnology Industry You Should Consider Buying

    20 Trending Stocks In Biotechnology Industry You Should Consider Buying

    Investors are always looking for safe and secure investments and as a strong and profitable industry, the biotechnology industry is considered to be an attractive area of investment. This industry has experienced massive growth in recent years and is continuously adopting new technological advancements to keep pace with the fast-growing market. Biotechnology is a set of tools that uses living organisms to create or change a product, improve plants, trees, or animals, or develop microorganisms for specific uses.

    Modern Biotechnology’s main focus is on medicine. The companies in this sector are involved in the development of new treatments for various complex diseases. Technology has always been at the heart of the biotechnology industry. As the new technologies emerged with the passage of time the efficiency of companies has also improved. Similarly, technological advancements have also changed the clinical trial process.

    There are various other trends that the companies are following. Let see the top 20 companies in the biotechnology industry to get a better view:

    Cassava Sciences Inc. (NASDAQ: SAVA)

    Cassava Sciences Inc. (NASDAQ: SAVA) last closed at $11.47, in a 52-week range of $1.05 to $11.25. Analysts have a consensus price target of $17.00. Cassava Sciences Inc. (SAVA) has earlier announced the results of the Phase 2b study with its drug candidate Sumifilam, in Alzheimer’s disease. The clinical study which has received the funding by the National Institutes of Health (NIH) has shown the improvement in Alzheimer’s disease. Cassava Sciences Inc. (SAVA) market cap has remained high, hitting $242.02 M at the time of writing.

    Inovio Pharmaceuticals Inc. (NASDAQ: INO)

    Inovio Pharmaceuticals Inc. (NASDAQ: INO) stock soar by 10.21% to $16.94. The most recent rating by ROTH Capital, on July 01, 2020, is at a Sell. Inovio Pharmaceuticals Inc. (INO) has revealed that the US Food and Drug Administration (FDA) has informed the company that it has some questions related to the Phase 2/3 trial of its COVID-19 vaccine candidate INO-4800, including its CELLECTRA 2000 delivery device to be used in the trial. the company said that it will halt the trial until it clear all the ambiguities of FDA.

    Sorrento Therapeutics Inc. (NASDAQ: SRNE)

    Sorrento Therapeutics Inc. (NASDAQ: SRNE) Shares headed rising, higher as much as 4.84%. The most recent rating by H.C. Wainwright, on July 31, 2020, is at a Buy. Sorrento Therapeutics Inc. (SRNE) has earlier revealed the results of its’ multicenter, open-label, Phase 1b Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for the Treatment of Intractable Cancer Pain at the 14th Annual Pain Therapeutics Summit. The company has reported the encouraging results from its Phase 1b study to evaluate Epidural Resiniferatoxin Injection.

    Vaxart Inc. (NASDAQ: VXRT)

    Vaxart Inc. (NASDAQ: VXRT) rose 7.40% after gaining more than $0.51 on Friday. Pomerantz LLP is investigating claims on behalf of investors of Vaxart, Inc. Vaxart Inc. share price went from a low point around $0.25 to briefly over $17.49 in the past 52 weeks, though shares have since pulled back to $7.40. Vaxart Inc.’s market cap has remained high, hitting $752.43 M at the time of writing.

    Novavax Inc. (NASDAQ: NVAX)

    Novavax Inc. (NASDAQ: NVAX) stock soar by 10.86% to $113.56. The most recent rating by H.C. Wainwright, on August 06, 2020, is at a Buy. Par Sterile Products, LLC (Par Sterile) has entered into a non-exclusive agreement with Novavax, Inc. to provide fill-finish manufacturing services at its plant in Rochester, Michigan for NVX-CoV2373, Novavax’ COVID-19 vaccine candidate.

    Onconova Therapeutics Inc. (NASDAQ: ONTX)

    Onconova Therapeutics Inc. (NASDAQ: ONTX) Shares headed falling, lower as much as -3.23%. The most recent rating by H.C. Wainwright, on March 01, 2018, is at a Buy. Onconova Therapeutics Inc. (ONTX) earlier revealed that it has started the Phase 1 clinical trial in China for ON 123300 by its partner, HanX Biopharmaceuticals. Onconova has partnered with HanX Biopharmaceuticals in December 2017 for the development, registration, and commercialization of ON 123300 in China.

    Jaguar Health Inc. (NASDAQ: JAGX)

    Jaguar Health Inc. (NASDAQ: JAGX) last closed at $0.31, in a 52-week range of $0.29 to $1.38. Jaguar Health Inc. (JAGX) earlier revealed itis scheduled to participate in its first “Diarrhea Dialogues” virtual event on October 20 from 3:00 PM. The event, open to the financial and business community, will discuss the importance of supportive care for cancer patients as it relates to chronic lower GI tract distress, specifically with regard to debilitating diarrhea experienced as a result of cancer therapy.

    Zogenix Inc. (NASDAQ: ZGNX)

    Zogenix Inc. (NASDAQ: ZGNX) stock drop by -1.46% to $17.50. The most recent rating by Raymond James, on August 25, 2020, is at an Mkt perform. Zogenix Inc. (ZGNX) has revealed the pricing of its offering of $200,000,000 aggregate principal amount of 2.75% convertible senior notes due 2027 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

    Trevena Inc. (NASDAQ: TRVN)

    Trevena Inc. (NASDAQ: TRVN) Shares headed rising, higher as much as 4.04%. The most recent rating by Guggenheim, on September 14, 2020, is at a Buy. Trevena Inc. (TRVN) has earlier participated in three presentations at the virtual 2020 American College of Clinical Pharmacology (ACCP) Annual Meeting. The meetings have taken place from September 21st to 23rd, 2020.

    VBI Vaccines Inc. (NASDAQ: VBIV)

    VBI Vaccines Inc. (NASDAQ: VBIV) last closed at $3.08, in a 52-week range of $0.47 to $6.93. VBI Vaccines Inc. (VBIV) is scheduled to participate in upcoming presentations including Sci-B-Vac: Results on Ph3 Hep B vaccine, Targeting CMV for the development of effective GBM immunotherapy on September 29 and 30, 2020, respectively. It has today participated in the COVID-19 panel discussion on the topic: What existing treatments and vaccine development platforms show promise to control the rate of infection and spread?

    Brickell Biotech Inc. (NASDAQ: BBI)

    Brickell Biotech Inc. (NASDAQ: BBI) Shares headed rising, higher as much as 3.90%. The most recent rating by Lake Street, on August 28, 2020, is at a Buy. Brickell Biotech Inc. (BBI) has revealed that its Japanese development partner, Kaken Pharmaceutical Co., Ltd. has received approval to manufacture and market sofpironium bromide gel, 5% under the brand name ECCLOCK in Japan for the treatment of primary axillary (underarm) hyperhidrosis.

    VYNE Therapeutics Inc. (NASDAQ: VYNE)

    VYNE Therapeutics Inc. (NASDAQ: VYNE) Shares headed falling, lower as much as -6.17%. VYNE Therapeutics Inc. (VYNE) has revealed that the Company will host a physician symposium on AMZEEQ and ZILXI™ on Thursday, October 1, 2020. VYNE market cap has remained high, hitting $271.70-M at the time of writing.

    Acorda Therapeutics Inc. (NASDAQ: ACOR)

    Acorda Therapeutics Inc. (NASDAQ: ACOR) shares were trading up 30.13% at $0.62 at the time of writing on Friday. Acorda Therapeutics Inc. (NASDAQ: ACOR) share price went from a low point around $0.42 to briefly over $3.27 in the past 52 weeks, though shares have since pulled back to $0.62. ACOR market cap has remained high, hitting $22.70M at the time of writing, giving it a price-to-sales ratio of more than 0. If we look at the recent analyst rating ACOR, H.C. Wainwright downgraded coverage on ACOR shares with a Neutral rating.

    Moderna Inc. (NASDAQ: MRNA)

    Moderna Inc. (NASDAQ: MRNA) last closed at $69.47, in a 52-week range of $13.53 to $95.21. Analysts have a consensus price target of $91.90. Moderna Inc. (MRNA) has moved up 413.45% from its 52-weeks low and moved down -327.03% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 17.30. This company’s market capitalization has remained high, hitting $25.72 billion at the time of writing.

    iBio Inc. (AMEX: IBIO)

    iBio Inc. (AMEX: IBIO) rose 7.77% after gaining more than $0.15 on Friday. iBio Inc. (IBIO) share price went from a low point around $0.05 to briefly over $7.45 in the past 52 weeks, though shares have since pulled back to $2.08. iBio Inc. has moved up 4060.00% from its 52-weeks low and moved down -72.08% from its 52-weeks high.  IBIO market cap has remained high, hitting $336.61 M at the time of writing.

    Akebia Therapeutics Inc. (NASDAQ: AKBA)

    Akebia Therapeutics Inc. (NASDAQ: AKBA) rose 0.81% after gaining more than $0.02 on Friday.  In the past 52-weeks of trading, this company’s stock has fluctuated between the low of $2.34 and a high of $13.71. It has moved up 5.98% from its 52-weeks low and moved down -8191% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 2.30. This company’s market capitalization has remained high, hitting $347.50 million at the time of writing.

    Vaccinex Inc. (NASDAQ: VCNX)

    Vaccinex Inc. (NASDAQ: VCNX) stock drop by -1.10% to $1.79. The most recent rating by BTIG Research, on September 23, 2020, is at a Neutral. Vaccinex Inc. (VCNX) share price went from a low point around $1.70 to briefly over $12.23 in the past 52 weeks, though shares have since pulled back to $1.79. VCNX has moved up 5.29% from its 52-weeks low and moved down -85.36% from its 52-weeks high.  VCNX market cap has remained high, hitting $36.19M at the time of writing.

    Ocugen Inc. (NASDAQ: OCGN)

    Ocugen Inc. (NASDAQ: OCGN) rose 2.29% after gaining more than $0.0 on Friday. In the past 52-weeks of trading, this company’s stock has fluctuated between the low of $0.17 and a high of $16.80. It has moved up 78.53% from its 52-weeks low and moved down -98.19% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 3.30. This company’s market capitalization has remained high, hitting $40.03 million at the time of writing.

    9 Meters Biopharma Inc. (NASDAQ: NMTR)

    9 Meters Biopharma Inc. (NMTR) last closed at $0.76, in a 52-week range of $0.37 to $1.22. 9 Meters Biopharma Inc. (NMTR) has moved up 106.59% from its 52-weeks low and moved down -37.33% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 1.30. This company’s market capitalization has remained high, hitting $101.25 million at the time of writing.

    Clovis Oncology Inc. (NASDAQ: CLVS)

    Clovis Oncology Inc. (NASDAQ: CLVS) stock soar by 3.25% to $5.88. The most recent rating by H.C. Wainwright, on May 18, 2020, is at a Buy. Clovis Oncology Inc. (CLVS) share price went from a low point around $2.93 to briefly over $17.37 in the past 52 weeks, though shares have since pulled back to $5.88. CLVS has moved up 100.68% from its 52-weeks low and moved down -66.15% from its 52-weeks high.  CLVS market cap has remained high, hitting $502.33M at the time of writing.

     

  • Stocks to Watch as Positive U.S-China Trade News Drive-up Markets

    Stocks to Watch as Positive U.S-China Trade News Drive-up Markets

    The markets are up this morning driven by news that the U.S and China are making progress in their trade negotiations. According to the U.S trade negotiator Robert Lighthizer and his Chinese colleague, the two countries were fully committed to ensuring that the negotiations turn out successful.

    This reassurance has led to higher appetite for stocks due to the reduced geopolitical risks. According to Naeem Aslam of Avatrade, the possible positive outcome of the trade negotiations between the two largest economies in the world had taken away a major barrier in the global stock markets.

    The news also come at a time when another risk factor to the economy seems to be falling under control. On Sunday the FDA approved the use of blood plasma in the treatment of COVID-19. In the event that it shows widespread effectiveness, then it would be a green light for the world economy to go back to normal. At the same time, hopes of a COVID-19 vaccine are rising by the day.

    Several biopharma companies and academic institutions are in advanced stages in the race for a vaccine. This has added an extra layer of positive sentiment in the market. In this environment of high optimism, stocks with positive news or anticipated positive news are rallying. Some of the top performers ahead of markets are as below:

    Viveve Medical Inc [NASDAQ: VIVE]

    Viveve is a top performer pre-market and is up b 41% at the time of writing. This comes after the company announced that it has positive primary efficacy data from its Stress Urinary Incontinence (SUI) feasibility study that done over 5-months.

    The company also announced that it had got positive results from its in-vivo pre-clinical study that was done to test the company’s new inert sham that would be used in the upcoming PURSUIT trial in the U.S. Commenting on the results, CEO Scott Durbin stated that they believed that the results were in support of the company’s thesis stating that cryogen-cooling had a good therapeutic effect. The results are likely to support this stock through the day.

    Ocugen Inc [NASDAQ: OCGN]

    Ocugen Inc is another top perfumer this morning and is up by 19%. This comes as investors await news from the company about its forward-looking statements. The stock is also buoyed by the fact that an insider recently bought a sizeable amount of the stock.  The company’s founder Shankar Musunari bought $108k worth of stock, an indicator that he has confidence in the company.

    Vivopower International PLC [NASDAQ: VVPR]

    This is another top performer this morning and is up by 18%. This follows the company’s release of its finances for the financial year ending 30th June 2020. The company reported that revenues grew by 12% compared to the last financial year.  The company also reported that gross revenues grew by 28% compared to the last financial year.  This has inspired investor confidence in the stock pre-market.